USD 1.0
(0.0%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 | 632.89 Thousand USD | 14.31% |
2023 | 553.68 Thousand USD | 18.68% |
2022 | 466.53 Thousand USD | -73.89% |
2021 | 1.78 Million USD | 1187.71% |
2020 | 138.74 Thousand USD | 1473.07% |
2019 | 8820.00 USD | 0.0% |
2014 | 14.7 Thousand USD | 14454.46% |
2013 | 101.00 USD | 0.0% |
2012 | - USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 FY | 632.89 Thousand USD | 14.31% |
2024 Q1 | 568.09 Thousand USD | 2.6% |
2024 Q2 | 577.99 Thousand USD | 1.74% |
2024 Q3 | 592.22 Thousand USD | 2.46% |
2024 Q4 | 632.89 Thousand USD | 6.87% |
2023 Q2 | 540.97 Thousand USD | -1.89% |
2023 Q1 | 551.37 Thousand USD | 18.19% |
2023 Q4 | 553.68 Thousand USD | 0.1% |
2023 FY | 553.68 Thousand USD | 18.68% |
2023 Q3 | 553.14 Thousand USD | 2.25% |
2022 Q3 | 393.67 Thousand USD | -12.62% |
2022 Q2 | 450.5 Thousand USD | -79.1% |
2022 Q1 | 2.15 Million USD | 20.66% |
2022 FY | 466.53 Thousand USD | -73.89% |
2022 Q4 | 466.53 Thousand USD | 18.51% |
2021 Q2 | 819.36 Thousand USD | 125.44% |
2021 Q3 | 1.46 Million USD | 79.12% |
2021 Q4 | 1.78 Million USD | 21.73% |
2021 FY | 1.78 Million USD | 1187.71% |
2021 Q1 | 363.45 Thousand USD | 161.96% |
2020 Q2 | 11.7 Thousand USD | 0.0% |
2020 FY | 138.74 Thousand USD | 1473.07% |
2020 Q4 | 138.74 Thousand USD | 234.89% |
2020 Q3 | 41.43 Thousand USD | 253.92% |
2020 Q1 | - USD | 0.0% |
2019 FY | 8820.00 USD | 0.0% |
2015 Q1 | 381.34 Thousand USD | 2494.15% |
2015 Q3 | 305.8 Thousand USD | 5.35% |
2015 Q2 | 290.26 Thousand USD | -23.88% |
2014 Q2 | 101.00 USD | 0.0% |
2014 Q1 | 101.00 USD | 0.0% |
2014 Q4 | 14.7 Thousand USD | 14454.46% |
2014 FY | 14.7 Thousand USD | 14454.46% |
2014 Q3 | 101.00 USD | 0.0% |
2013 FY | 101.00 USD | 0.0% |
2013 Q4 | 101.00 USD | -36.88% |
2013 Q2 | 160.00 USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2013 Q3 | 160.00 USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
GSRX Industries Inc. | - USD | -Infinity% |
High Sierra Technologies, Inc. | 611.78 Thousand USD | -3.451% |
Instadose Pharma Corp. | - USD | -Infinity% |